Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
289.00 CHF | +0.45% |
|
+1.05% | +13.11% |
Voraussichtliche Gewinn- und Verlustrechnung: Roche Holding AG
Steuerjahr: Dezember | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Umsatz 1 | 58’323 | 62’801 | 63’281 | 58’716 | 60’495 | 64’727 | 67’197 | 69’902 |
Veränderung | - | 7.68% | 0.76% | -7.21% | 3.03% | 7% | 3.82% | 4.03% |
EBITDA 1 | 24’281 | 24’692 | 25’015 | 21’976 | 23’538 | 26’257 | 26’866 | 28’324 |
Veränderung | - | 1.69% | 1.31% | -12.15% | 7.11% | 11.55% | 2.32% | 5.43% |
Betriebsergebnis (EBIT) 1 | 21’536 | 21’897 | 22’173 | 19’240 | 20’823 | 22’833 | 24’088 | 25’146 |
Veränderung | - | 1.68% | 1.26% | -13.23% | 8.23% | 9.65% | 5.49% | 4.39% |
Gezahlte Zinsen 1 | -578 | -757 | -1’214 | -1’300 | -1’610 | -1’352 | -1’268 | -1’097 |
Gewinn vor Steuern (EBT) 1 | 17’965 | 17’398 | 16’327 | 14’079 | 11’793 | 20’699 | 20’950 | 22’747 |
Veränderung | - | -3.16% | -6.16% | -13.77% | -16.24% | 75.52% | 1.21% | 8.58% |
Nettoergebnis 1 | 14’295 | 13’930 | 12’421 | 11’498 | 8’277 | 15’522 | 15’772 | 17’167 |
Veränderung | - | -2.55% | -10.83% | -7.43% | -28.01% | 87.53% | 1.61% | 8.85% |
Datum der Veröffentlichung | 04.02.21 | 03.02.22 | 02.02.23 | 01.02.24 | 30.01.25 | - | - | - |
Vorläufige Bilanz: Roche Holding AG
Steuerjahr: Dezember | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Nettoverschuldung 1 | 1’882 | 18’167 | 15’584 | 18’699 | 17’337 | 10’772 | 3’655 | -6’950 |
Veränderung | - | 865.3% | -14.22% | 19.99% | -7.28% | -37.87% | -66.07% | -290.15% |
Datum der Veröffentlichung | 04.02.21 | 03.02.22 | 02.02.23 | 01.02.24 | 30.01.25 | - | - | - |
Prognostizierter Cashflow: Roche Holding AG
Steuerjahr: Dezember | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
CAPEX Investitionsaufwand 1 | 3’528 | 3’693 | 3’449 | 3’742 | 3’529 | 3’938 | 4’090 | 4’206 |
Veränderung | - | 4.68% | -6.61% | 8.5% | -5.69% | 11.58% | 3.88% | 2.83% |
Free Cashflow (FCF) 1 | 10’943 | 15’691 | 13’041 | 11’288 | 15’336 | 16’297 | 16’458 | 17’580 |
Veränderung | - | 43.39% | -16.89% | -13.44% | 35.86% | 6.26% | 0.99% | 6.82% |
Datum der Veröffentlichung | 04.02.21 | 03.02.22 | 02.02.23 | 01.02.24 | 30.01.25 | - | - | - |
Voraussichtliche Finanzkennzahlen: Roche Holding AG
Steuerjahr: Dezember | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Rentabilität | ||||||||
EBITDA-Marge (%) | 41.63% | 39.32% | 39.53% | 37.43% | 38.91% | 40.57% | 39.98% | 40.52% |
EBIT-Marge (%) | 36.93% | 34.87% | 35.04% | 32.77% | 34.42% | 35.28% | 35.85% | 35.97% |
EBT-Marge (%) | 30.8% | 27.7% | 25.8% | 23.98% | 19.49% | 31.98% | 31.18% | 32.54% |
Nettogewinn (%) | 24.51% | 22.18% | 19.63% | 19.58% | 13.68% | 23.98% | 23.47% | 24.56% |
FCF-Marge N (%) | 18.76% | 24.99% | 20.61% | 19.22% | 25.35% | 25.18% | 24.49% | 25.15% |
FCF / Nettogewinn (%) | 76.55% | 112.64% | 104.99% | 98.17% | 185.28% | 104.99% | 104.35% | 102.4% |
Rentabilität | ||||||||
ROA | 19.59% | 19.09% | 18.18% | 16.71% | 15.69% | 15.53% | 15.11% | 14.7% |
ROE | 47.99% | 56.02% | 62.5% | 45.73% | 43.45% | 42.54% | 37.47% | 32.54% |
Finanzielle Gesundheit | ||||||||
Verschuldungsgrad (Verbindlichkeiten/EBITDA) | 0.08x | 0.74x | 0.62x | 0.85x | 0.74x | 0.41x | 0.14x | - |
Verschuldung / Free Cashflow | 0.17x | 1.16x | 1.2x | 1.66x | 1.13x | 0.66x | 0.22x | - |
Kapitalintensität | ||||||||
CAPEX / Umsatz (%) | 6.05% | 5.88% | 5.45% | 6.37% | 5.83% | 6.08% | 6.09% | 6.02% |
CAPEX / EBITDA (%) | 14.53% | 14.96% | 13.79% | 17.03% | 14.99% | 15% | 15.23% | 14.85% |
CAPEX / FCF (%) | 32.24% | 23.54% | 26.45% | 33.15% | 23.01% | 24.16% | 24.85% | 23.93% |
Elemente pro Aktie | ||||||||
Cashflow pro Aktie 1 | 21.46 | 24.39 | 22.79 | 20.02 | 25.05 | 24.62 | 26.59 | 27.22 |
Veränderung | - | 13.64% | -6.56% | -12.16% | 25.16% | -1.73% | 8.01% | 2.36% |
Dividende pro Aktie 1 | 9.1 | 9.3 | 9.5 | 9.6 | 9.7 | 9.893 | 10.12 | 10.36 |
Veränderung | - | 2.2% | 2.15% | 1.05% | 1.04% | 1.99% | 2.32% | 2.34% |
Buchwert je Aktie 1 | 42.5 | 28.81 | 35.03 | 41.37 | 45.09 | 49.29 | 60.78 | 73.86 |
Veränderung | - | -32.22% | 21.58% | 18.12% | 8.98% | 9.32% | 23.31% | 21.53% |
Gewinn pro Aktie 1 | 16.52 | 16.2 | 15.37 | 14.31 | 10.31 | 19.17 | 20.38 | 21.43 |
Veränderung | - | -1.94% | -5.12% | -6.9% | -27.95% | 85.97% | 6.32% | 5.15% |
Anz. der Aktien (in Tausend) | 854’642 | 800’952 | 854’579 | 798’652 | 796’789 | 795’401 | 795’401 | 795’401 |
Datum der Veröffentlichung | 04.02.21 | 03.02.22 | 02.02.23 | 01.02.24 | 30.01.25 | - | - | - |
2025 * | 2026 * | |
---|---|---|
KGV | 15.1x | 14.2x |
KBV | 5.86x | 4.76x |
EV / Sales | 3.75x | 3.51x |
Rendite | 3.42% | 3.5% |
Gewinn pro Aktie & Dividende
Historische Entwicklung KGV
Entwicklung der Dividendenrendite

Quartalsumsätze - Abweichungsrate
- Börse
- Aktien
- 855167 Aktie
- Finanzen Roche Holding AG

MarketScreener is also available in this country: United States.
Switch edition